Further learning of clinical characteristics and imaging manifestations of nonketotic hyperglycemic hemichorea
Fuente:
Wiley Open Access
Salvato in:
| Autori principali: | Xiaoyu Wang, Yuting Zhang, Fan Yang, Suqing Bao, Lijun Duan, Xia Jiang |
|---|---|
| Natura: | Artículo Open Access |
| Pubblicazione: |
Wiley
2024
|
| Soggetti: | |
| Accesso online: | |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne!!
|
Documenti analoghi
Trends in diabetic ketoacidosis‐ and hyperosmolar hyperglycemic state‐related mortality during theCOVID‐19 pandemic in the United States: A population‐based study
di: Xinyuan He, et al.
Pubblicazione: (2024)
di: Xinyuan He, et al.
Pubblicazione: (2024)
Age‐related variations in clinical characteristics of patients with diabetic foot ulcers
di: Hong‐ping Gong, et al.
Pubblicazione: (2025)
di: Hong‐ping Gong, et al.
Pubblicazione: (2025)
Mitochondrial Homeostasis in Pancreatic β Cell Function: Mechanisms and Therapeutic Targets for Diabetes
di: Ruihan Li, et al.
Pubblicazione: (2026)
di: Ruihan Li, et al.
Pubblicazione: (2026)
Research on the characteristics of gut microbiota in overweight patients with early‐onset type 2 diabetes mellitus
di: Ke Huang, et al.
Pubblicazione: (2025)
di: Ke Huang, et al.
Pubblicazione: (2025)
Targeting SIRT3 to Ameliorate Diabetic Cardiomyopathy: Progress in Mechanistic Research and Prospects for Clinical Translation
di: Yuting Lin, et al.
Pubblicazione: (2025)
di: Yuting Lin, et al.
Pubblicazione: (2025)
Trends in clinical characteristics, medication use, and glycemic control in insulin‐treated patients with type 1 and type 2 diabetes in Finland in 2012–2019: Nationwide real‐world evidence study
di: Leo Niskanen, et al.
Pubblicazione: (2024)
di: Leo Niskanen, et al.
Pubblicazione: (2024)
Recent drug development of dorzagliatin, a new glucokinase activator, with the potential to treat Type 2 diabetes: A review study
di: Yu Jiang, et al.
Pubblicazione: (2024)
di: Yu Jiang, et al.
Pubblicazione: (2024)
The Interaction Between Mitophagy Dysregulation and the Diabetic Bladder Microenvironment
di: Shi Li, et al.
Pubblicazione: (2026)
di: Shi Li, et al.
Pubblicazione: (2026)
Clinical characteristics and complication risks in data‐driven clusters among Chinese community diabetes populations
di: Binqi Li, et al.
Pubblicazione: (2024)
di: Binqi Li, et al.
Pubblicazione: (2024)
Comment on “A machine learning approach to predicting severe diabetes distress in adults with type 1 diabetes mellitus”
di: Yindan Song, et al.
Pubblicazione: (2026)
di: Yindan Song, et al.
Pubblicazione: (2026)
Fatty Acid Binding Protein 4 Regulates the Antigen‐Presenting Function of Dendritic Cells Resulting in T Cell Priming in Streptozotocin‐Induced Type 1 Diabetes Mice
di: Hailan Zou, et al.
Pubblicazione: (2025)
di: Hailan Zou, et al.
Pubblicazione: (2025)
Acellular fish skin grafts in the treatment of diabetic wounds: Advantages and clinical translation
di: Chenyu Zhao, et al.
Pubblicazione: (2024)
di: Chenyu Zhao, et al.
Pubblicazione: (2024)
PIONEER REAL Japan: Baseline characteristics of a multicenter, prospective, real‐world study of oral semaglutide in adults with type 2 diabetes in clinical practice in Japan
di: Ryo Suzuki, et al.
Pubblicazione: (2024)
di: Ryo Suzuki, et al.
Pubblicazione: (2024)
Resveratrol delays the progression of diabetic nephropathy through multiple pathways: A dose–response meta‐analysis based on animal models
di: Xiaojing Liu, et al.
Pubblicazione: (2024)
di: Xiaojing Liu, et al.
Pubblicazione: (2024)
Thyroid‐Stimulating Hormone Regulates the Glucose Metabolism in Hepatocytes via Toll‐Like Receptor 4/Tollip Pathway
di: Suqing Bao, et al.
Pubblicazione: (2025)
di: Suqing Bao, et al.
Pubblicazione: (2025)
Causal association between circulating leukocyte characteristics and diabetic retinopathy based on two‐sample Mendelian randomization
di: Yan Wang, et al.
Pubblicazione: (2025)
di: Yan Wang, et al.
Pubblicazione: (2025)
Association of systolic blood pressure variability with cognitive decline in type 2 diabetes: A post hoc analysis of a randomized clinical trial
di: Junmin Chen, et al.
Pubblicazione: (2024)
di: Junmin Chen, et al.
Pubblicazione: (2024)
Prevalence, Awareness, Treatment, and Control of Diabetes Among 0.98 Million Patients With Stroke/TIA in China: Insights From a Nationwide Cohort Study
di: Siqi Chen, et al.
Pubblicazione: (2025)
di: Siqi Chen, et al.
Pubblicazione: (2025)
Association Between Serum Lycopene Concentrations and Diabetic Kidney Disease in the Elderly With Diabetes Mellitus: A Cross‐Sectional Study From the NHANES Database
di: Shumin Bao, et al.
Pubblicazione: (2025)
di: Shumin Bao, et al.
Pubblicazione: (2025)
Machine learning‐based risk prediction model for neuropathic foot ulcers in patients with diabetic peripheral neuropathy
di: Ge Shi, et al.
Pubblicazione: (2025)
di: Ge Shi, et al.
Pubblicazione: (2025)
Insights Into Macrophage Polarization and M1 / M2 Balance in Diabetic Foot Ulcers
di: Jing Zhang, et al.
Pubblicazione: (2026)
di: Jing Zhang, et al.
Pubblicazione: (2026)
Sex Differences in the Efficacy of Glucagon‐Like Peptide‐1 Receptor Agonists for Weight Reduction: A Systematic Review and Meta‐Analysis
di: Yucheng Yang, et al.
Pubblicazione: (2025)
di: Yucheng Yang, et al.
Pubblicazione: (2025)
Prevalence of nonalcoholic fatty liver disease and liver cirrhosis in Chinese adults with type 2 diabetes mellitus
di: Xinyu Han, et al.
Pubblicazione: (2024)
di: Xinyu Han, et al.
Pubblicazione: (2024)
Single‐Cell RNA Sequencing Shows Exercise Protects db/db Mouse Pancreatic Injuries by Regulating Endothelial Cell Homeostasis
di: Wenya Weng, et al.
Pubblicazione: (2025)
di: Wenya Weng, et al.
Pubblicazione: (2025)
First‐Degree Family History of Diabetes Is Associated With the Presence of Depressive Symptoms Independent of Lifestyle Risk Factors and Cardiometabolic Risk Factors
di: Mengying Chen, et al.
Pubblicazione: (2025)
di: Mengying Chen, et al.
Pubblicazione: (2025)
Advancements and Challenges in Immune Protection Strategies for Islet Transplantation
di: Xue Wang, et al.
Pubblicazione: (2025)
di: Xue Wang, et al.
Pubblicazione: (2025)
The Role of Negative Pressure Therapy in Diabetic Foot Ulcer: A Meta‐Analysis
di: Hai Du, et al.
Pubblicazione: (2026)
di: Hai Du, et al.
Pubblicazione: (2026)
The potential adverse effects of hypodermic glucagon‐like peptide ‐1 receptor agonist on patients with type 2 diabetes: A population‐based study
di: Zhiyuan Cheng, et al.
Pubblicazione: (2024)
di: Zhiyuan Cheng, et al.
Pubblicazione: (2024)
Correlation between time in range and mild cognitive impairment in older adults with type 2 diabetes mellitus
di: Jiajun Bao, et al.
Pubblicazione: (2025)
di: Jiajun Bao, et al.
Pubblicazione: (2025)
Costunolide Reduces DN Inflammatory Response and Renal Thrombosis by Inhibiting NET Formation
di: Xiangjing Wang, et al.
Pubblicazione: (2025)
di: Xiangjing Wang, et al.
Pubblicazione: (2025)
Critical methodological concerns regarding the nomogram prediction model for DKA in elderly diabetic patients
di: Xiaoyan Zhang, et al.
Pubblicazione: (2025)
di: Xiaoyan Zhang, et al.
Pubblicazione: (2025)
Commentary on the T1D exchange quality improvement collaborative learning session November 2023 abstracts
di: Shideh Majidi, et al.
Pubblicazione: (2024)
di: Shideh Majidi, et al.
Pubblicazione: (2024)
Diabetic Retinopathy and Cognitive Dysfunction in Type 2 Diabetes Mellitus: A Systematic Review and Meta‐Analysis of Epidemiological Associations and Clinical Implications
di: Ye He, et al.
Pubblicazione: (2026)
di: Ye He, et al.
Pubblicazione: (2026)
Oxidative stress suppresses PHB2‐mediated mitophagy in β‐cells via the Nrf2/PHB2 pathway
di: Shan Liu, et al.
Pubblicazione: (2024)
di: Shan Liu, et al.
Pubblicazione: (2024)
Pharmacological characteristics of once‐weekly insulin icodec in Japanese individuals with type 1 diabetes
di: Takashi Eto, et al.
Pubblicazione: (2024)
di: Takashi Eto, et al.
Pubblicazione: (2024)
Gut Microbiota and Their Metabolites: The Hidden Driver of Diabetic Nephropathy? Unveiling Gut Microbe's Role in DN
di: Jinzhou Liu, et al.
Pubblicazione: (2025)
di: Jinzhou Liu, et al.
Pubblicazione: (2025)
A nomogram incorporating clinical and laboratory indicators for predicting metabolic dysfunction‐associated fatty liver disease in newly diagnosed type 2 diabetes patients
di: Tingting Li, et al.
Pubblicazione: (2025)
di: Tingting Li, et al.
Pubblicazione: (2025)
Potential mechanisms of metabolic reprogramming induced by ischemia–reperfusion injury in diabetic myocardium
di: Haiping Ma, et al.
Pubblicazione: (2024)
di: Haiping Ma, et al.
Pubblicazione: (2024)
Phenotypic characteristics of diabetic neuropathic pain and factors associated in patients with Diabetes Mellitus‐type 2
di: Helena De Sola, et al.
Pubblicazione: (2025)
di: Helena De Sola, et al.
Pubblicazione: (2025)
miR‐92a aggravates metabolic syndrome via KLF2/miR‐483 axis
di: Zhe Zhao, et al.
Pubblicazione: (2025)
di: Zhe Zhao, et al.
Pubblicazione: (2025)
Documenti analoghi
-
Trends in diabetic ketoacidosis‐ and hyperosmolar hyperglycemic state‐related mortality during theCOVID‐19 pandemic in the United States: A population‐based study
di: Xinyuan He, et al.
Pubblicazione: (2024) -
Age‐related variations in clinical characteristics of patients with diabetic foot ulcers
di: Hong‐ping Gong, et al.
Pubblicazione: (2025) -
Mitochondrial Homeostasis in Pancreatic β Cell Function: Mechanisms and Therapeutic Targets for Diabetes
di: Ruihan Li, et al.
Pubblicazione: (2026) -
Research on the characteristics of gut microbiota in overweight patients with early‐onset type 2 diabetes mellitus
di: Ke Huang, et al.
Pubblicazione: (2025) -
Targeting SIRT3 to Ameliorate Diabetic Cardiomyopathy: Progress in Mechanistic Research and Prospects for Clinical Translation
di: Yuting Lin, et al.
Pubblicazione: (2025)